{"brief_title": "Subcutaneous Amifostine (Ethyol\u00ae) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer", "brief_summary": "The primary objective of this study is to assess the activity of subcutaneous (SC) amifostine on the incidence and severity of acute radiochemotherapy-induced esophagitis in patients with unresectable Stage IIIA or IIIB non-small cell lung cancer (NSCLC) receiving combined modality therapy.", "condition": "Non-Small Cell Lung Carcinoma", "intervention_type": "Drug", "intervention_name": "Amifostine", "criteria": "You may be eligible for this study if you are 18 years of age or older and: - Have UnResectable Stage IIIA or IIIB Non Small Cell Lung Cancer - Have never had prior chemotherapy with Paclitaxel or Carboplatin - Have never had prior thoracic radiation therapy (XRT)", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00081315.xml"}